Vasovist Articles

Intercell's Ixiaro JE vacc recommended for EU approval

8 April 2009

Epix stock triples on Vasovist approval

12 January 2009

EPIX regains Vasovist rights from Bayer

15 September 2008

South Korea approves EPIX' Vasovist

21 July 2008

EPIX discontinues MDD drug on poor efficacy

31 March 2008

Bayer/Schering AG present R&D pipeline, highlighting Nexavar, Campath and Yaz

6 November 2006

Stock Commentary - Europe - week to Nov 28

5 December 2005

FDA accepts EPIX' Vasovist submission

11 July 2005

Positive CHMP opinion for Schering AG's Vasovist

4 July 2005

Schering AG commits to operating margin of 16% this year and 18% in 2006

4 July 2005

Showing 1-10 of 10 articles

Go to beginningPrevious
  • 1
NextGo to end